HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The long-term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis.

AbstractCONTEXT:
The high-dose short Synacthen (corticotropin) test (SST) is widely used to investigate suspected secondary adrenal insufficiency, but concern remains about falsely reassuring results.
OBJECTIVE:
Our objective was to evaluate the long-term safety of the SST.
METHOD:
We retrospectively evaluated the clinical outcome in 178 patients who achieved 30-min cortisol values in the lowest 15th percentile of normal healthy responses. Thirty patients were later excluded because of missing case notes (20 patients) or unsubstantiated pituitary pathology (10 patients). The remaining 148 patients were divided into two groups: group 1, patients with cortisol response between the 5th and 15th percentiles of normal response (551-635 nmol/liter, 98 patients); and group 2, patients with borderline response between the 2.5th and 5th percentiles (510-550 nmol/liter, 50 patients). Patients did not receive routine glucocorticoid therapy, but those in group 2 were advised to take hydrocortisone in case of intercurrent illness.
RESULTS:
The median follow-up period from the initial SST was 4.2 yr (range, 4 months to 7 yr). A total of 137 patients showed no clinical or biochemical evidence of adrenal insufficiency during follow-up. Of the remaining 11 patients, seven became hypoadrenal after subsequent pituitary surgery or radiotherapy, one patient in group 1 developed adrenal insufficiency at 2 yr, and one patient in group 2 developed adrenal insufficiency at 6 months. The other two patients who were in group 2 had clinical diagnostic uncertainty.
CONCLUSION:
The high-dose SST is safe for the purpose of excluding clinically significant secondary adrenal insufficiency and is indicated as the first line of investigation for this purpose.
AuthorsAmar Agha, Jeremy W Tomlinson, Penelope M Clark, Geoff Holder, Paul M Stewart
JournalThe Journal of clinical endocrinology and metabolism (J Clin Endocrinol Metab) Vol. 91 Issue 1 Pg. 43-7 (Jan 2006) ISSN: 0021-972X [Print] United States
PMID16249286 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Adrenocorticotropic Hormone
  • Hydrocortisone
Topics
  • Adenoma (diagnosis, surgery)
  • Adolescent
  • Adrenal Insufficiency (diagnosis)
  • Adrenocorticotropic Hormone
  • Adult
  • Aged
  • Aged, 80 and over
  • Empty Sella Syndrome (diagnosis)
  • False Negative Reactions
  • Female
  • Follow-Up Studies
  • Humans
  • Hydrocortisone (blood, therapeutic use)
  • Hypophysectomy
  • Hypothalamo-Hypophyseal System (drug effects)
  • Infarction (diagnosis)
  • Male
  • Middle Aged
  • Pituitary Diseases (diagnosis)
  • Pituitary Function Tests
  • Pituitary Neoplasms (diagnosis, surgery)
  • Pituitary-Adrenal Function Tests
  • Predictive Value of Tests
  • Pregnancy
  • Retrospective Studies
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: